“Optogenetics Restores Vision in Retinitis Pigmentosa Trial: Half of Patients Regain Light ” — what this page in the network covers. A pioneering optogenetics trial has shown that gene therapy can restore some vision in people with advanced retinitis pigmentosa, a genetic disorder that causes progressive blindness. According to STAT News, about half of the patients in the small study regained photosensitivity—the ability of retinal cells to respond to light—after receiving a single injection of a light-sensitive protein. The treatment targets retinal ganglion cells, bypassing the damaged photoreceptors that normally capture light.
While the trial was small and the restored vision was limited to light perception rather than detailed sight, the results mark a significant step forward for a condition that currently has no cure. The approach could eventually be combined with other therapies to improve functional vision, and researchers are planning larger studies to confirm these early findings. This listing links straight to the original page, where the content is available in full.